Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice.


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
Oct 2021
Historique:
accepted: 18 05 2021
pubmed: 31 5 2021
medline: 1 3 2022
entrez: 30 5 2021
Statut: ppublish

Résumé

Murine atherosclerosis models are key for investigation of atherosclerosis pathophysiology and drug development. However, they do not feature spontaneous atherothrombosis as a final stage of atherosclerosis. Transgenic mice expressing both the human mutant apolipoprotein E form APOE*3-Leiden and human cholesteryl ester transfer protein (CETP), i.e. APOE*3-Leiden.CETP mice, feature a moderate hyperlipoproteinemia and atherosclerosis phenotype. In contrast to apolipoprotein E deficient (Apoe-

Identifiants

pubmed: 34052976
doi: 10.1007/s11239-021-02488-2
pii: 10.1007/s11239-021-02488-2
pmc: PMC8568858
doi:

Substances chimiques

Apolipoproteins E 0
Cholesterol Ester Transfer Proteins 0
Lipids 0
Pharmaceutical Preparations 0
Protein C 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

715-719

Subventions

Organisme : Trombosestichting Nederland
ID : 2018-1

Informations de copyright

© 2021. The Author(s).

Références

Nat Commun. 2015 Mar 10;6:6356
pubmed: 25754609
Sci Rep. 2018 Oct 10;8(1):15106
pubmed: 30305662
Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):926-33
pubmed: 8696955
Blood. 2013 May 23;121(21):4413-6
pubmed: 23550037
Arterioscler Thromb Vasc Biol. 2017 May;37(5):782-785
pubmed: 28302625
Eur J Pharmacol. 2017 Dec 5;816:3-13
pubmed: 28483459
J Clin Invest. 1994 Apr;93(4):1403-10
pubmed: 8163645
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1706-21
pubmed: 17541027

Auteurs

Yvonne K Jongejan (YK)

Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Jeroen C J Eikenboom (JCJ)

Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Marion J J Gijbels (MJJ)

Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department of Molecular Genetics, Department of Pathology, Cardiovascular Research Institute Maastricht, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Jimmy F P Berbée (JFP)

Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.

Bart J M van Vlijmen (BJM)

Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. b.j.m.van_vlijmen@lumc.nl.
Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands. b.j.m.van_vlijmen@lumc.nl.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH